Article info
PDFSymposium on HIV and assisted reproductive technologies
Should HIV discordant couples have access to assisted reproductive technologies?
- Correspondence to: M Spriggs Ethics Unit, Murdoch Childrens Research Institute, Royal Childrens Hospital, Flemington Road, Parkville, Victoria 3052, Australia; spriggsmmurdoch.rch.unimelb.edu.au
Citation
Should HIV discordant couples have access to assisted reproductive technologies?
Publication history
- Accepted December 17, 2002
- First published December 8, 2003.
Online issue publication
December 08, 2003
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright 2003 by the Journal of Medical Ethics
Other content recommended for you
- Use of assisted reproductive technology to reduce the risk of transmission of HIV in discordant couples wishing to have their own children where the male partner is seropositive with an undetectable viral load
- Is it ethical to provide IVF add-ons when there is no evidence of a benefit if the patient requests it?
- Neurological sequelae in twins born after assisted conception: controlled national cohort study
- Assisted reproductive technologies do not enhance the variability of DNA methylation imprints in human
- Risk of prostate cancer for men fathering through assisted reproduction: nationwide population based register study
- The Uppsala–Stockholm Assisted Reproductive Techniques (UppStART) study
- Psychiatric disorders among women and men in assisted reproductive technology (ART) treatment. The Danish National ART-Couple (DANAC) cohort: protocol for a longitudinal, national register-based cohort study
- Intracytoplasmic sperm injection (ICSI) versus conventional in vitro fertilisation (IVF) in couples with non-severe male infertility (NSMI-ICSI): protocol for a multicentre randomised controlled trial
- Assisted reproductive technologies and equity of access issues
- NICE CG156: fertility update. What it means for general practitioners